Literature DB >> 26976687

CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.

Sohshi Morimura1, Tomonori Oka1, Makoto Sugaya2, Shinichi Sato1.   

Abstract

BACKGROUND: CX3C chemokine receptor 1 (CX3CR1), a receptor for CX3CL1, mediates migration of inflammatory cells. Psoriasis is a common skin disorder that causes skin inflammation. The role of CX3CL1 and CX3CR1 in psoriasis remains unclear.
OBJECTIVE: To elucidate the role of CX3CL1 and CX3CR1 in psoriasis, we assessed imiquimod-induced psoriasis-like dermatitis in CX3CR1-deficient mice.
METHODS: We evaluated skin inflammation by assessing erythema, scaling, and ear thickness in CX3CR1(-/-) mice and wild-type (WT) mice. Furthermore, we measured cytokine production by quantitative reverse transcription-PCR. We investigated infiltrating cells in skin by immunohistochemistry and flow cytometry. After confirming phenotypical differences in macrophages between WT and CX3CR1(-/-) mice, we analyzed expression levels of IL-1β, IL-6, and TNF-α in peritoneal macrophages with or without stimulation of CX3CL1. We finally transferred peritoneal macrophages into the ear before IMQ application.
RESULTS: Skin inflammation assessed by erythema, scaling, and epidermal thickness was significantly reduced in CX3CR1(-/-) mice compared with wild-type (WT) mice, accompanied by decreases in cytokine production for IL-12, IL-23, IL-17A, IL-22, IL-1β, IL-6, TNF-α, and IL-36. On day 6, increase in ear thickness from the baseline of CX3CR1(-/-) mice was one third of that of WT mice. Skin macrophages of CX3CR1(-/-) mice contained increased levels of CCR2 and decreased levels of MCP-1 compared with those from WT mice. Spontaneous expression levels of IL-1β, IL-6, and TNF-α in peritoneal macrophages of naïve CX3CR1(-/-) mice were significantly lower than those of WT mice. Furthermore, stimulation of WT macrophages with CX3CL1 decreased expression of these cytokines, suggesting that altered macrophage populations, but not loss of interaction between CX3CL1 and CX3CR1 signaling, caused differences in cytokine expression and skin inflammation. Moreover, transfer of macrophages from WT mice normalized IMQ-induced psoriasis-like inflammation in CX3CR1(-/-) mice, suggesting that macrophages contributed to the decreased inflammation resulted from CX3CR1 deficiency.
CONCLUSION: These data show that interactions between CX3CL1 and CX3CR1 play important roles for infiltration of M1 macrophages in a non-inflammatory setting. Decreased M1 macrophages in naïve CX3CR1(-/-) mice may be related to decreased cytokine expression and attenuated psoriasis-like inflammation.
Copyright © 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CX3CL1; CX3CR1; Imiquimod; M1 macrophage; Psoriasis

Mesh:

Substances:

Year:  2016        PMID: 26976687     DOI: 10.1016/j.jdermsci.2016.03.004

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  11 in total

1.  CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.

Authors:  Lu-Ying Li; Ke-Min Yin; Yi-Han Bai; Zhi-Gang Zhang; Wen Di; Shu Zhang
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

Review 2.  Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

3.  CX3CR1 Deficiency Attenuates DNFB-Induced Contact Hypersensitivity Through Skewed Polarization Towards M2 Phenotype in Macrophages.

Authors:  Sayaka Otobe; Teruyoshi Hisamoto; Tomomitsu Miyagaki; Sohshi Morimura; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

Review 4.  Macrophages play a role in inflammatory transformation of colorectal cancer.

Authors:  Lu Lu; Yu-Jing Liu; Pei-Qiu Cheng; Dan Hu; Han-Chen Xu; Guang Ji
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

5.  Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.

Authors:  Ajla Smajlović; Anja Haverić; Amer Alić; Maida Hadžić; Ahmed Smajlović; Indira Mujezinović; Naida Lojo-Kadrić; Jasmin Ramić; Nikolina Elez-Burnjaković; Sanin Haverić; Lejla Pojskić
Journal:  Mol Biol Rep       Date:  2021-06-07       Impact factor: 2.316

Review 6.  Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis.

Authors:  Isabelle Lorthois; Daniel Asselineau; Nathalie Seyler; Roxane Pouliot
Journal:  Mediators Inflamm       Date:  2017-11-08       Impact factor: 4.711

7.  MicroRNA-17-92 cluster promotes the proliferation and the chemokine production of keratinocytes: implication for the pathogenesis of psoriasis.

Authors:  Weigang Zhang; Xiuli Yi; Yawen An; Sen Guo; Shuli Li; Pu Song; Yuqian Chang; Shaolong Zhang; Tianwen Gao; Gang Wang; Chunying Li
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

8.  IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice.

Authors:  Kozo Nakai; Yu-Ying He; Fumiko Nishiyama; Fukiko Naruse; Reiji Haba; Yoshio Kushida; Naomi Katsuki; Tetsuya Moriue; Kozo Yoneda; Yasuo Kubota
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

9.  Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis.

Authors:  Siegfried Bezdek; Lin Leng; Hauke Busch; Sadegh Mousavi; Dirk Rades; Markus Dahlke; Detlef Zillikens; Richard Bucala; Christian D Sadik
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

10.  Identification of Hub Genes and Immune Infiltration in Psoriasis by Bioinformatics Method.

Authors:  Wenxing Su; Yuqian Wei; Biao Huang; Jiang Ji
Journal:  Front Genet       Date:  2021-02-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.